ADVANCE: Impact of Spiroergometer Parameters as Diagnostic Marker of Cardiac Ischemia in Pts. With Stable Angina Compared to FFR.

Sponsor
Jena University Hospital (Other)
Overall Status
Recruiting
CT.gov ID
NCT04450459
Collaborator
(none)
100
1
52.9
1.9

Study Details

Study Description

Brief Summary

In Patients with stable Angina pectoris CCS 1-3 exercise testing for ischemia detection is widely used despite the known limitations. Measurement of the FFR is invasive but gold standard for Ischemia detection.

Adding of parameters of spiroergometer might help to improve diagnostic accuracy of non invasive exercise testing. Therefore the trial is evaluating diagnostic accuracy of spiroergometric parameters compared to invasive FFR measurement.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: ergospirometer test

Study Design

Study Type:
Observational
Anticipated Enrollment :
100 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Impact of Ergospirometric Oxygen Uptake Under Exercise as Diagnostic Marker of Cardiac Ischemia in Patients With Stable Angina Compared to Non Invasive and Invasive (FFR) Measurement of Ischemia
Actual Study Start Date :
Jan 2, 2019
Anticipated Primary Completion Date :
Jan 1, 2023
Anticipated Study Completion Date :
Jun 1, 2023

Outcome Measures

Primary Outcome Measures

  1. double slope sign of ΔV̇O2/ΔWR-Increase [baseline]

    double slope sign of ΔV̇O2/ΔWR by ergospirometer test

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Inclusion Criteria:
  • stable Angina (CCS >1-3) with suspected CAD or

  • dyspnoea at exertion NYHA >2 or

  • signs of ischemia within SPECT or exercise electrocardiography

  • willingness to participate in the trial

Exclusion Criteria:
  • Unstable angina or myocardial infarction within the last 2 weeks

  • inability to perform bicycle exercise test

  • significant valvular disease

  • HOCM

  • av- block >I degree

  • asthma bronchiales

Contacts and Locations

Locations

Site City State Country Postal Code
1 Universityhospital Jena Germany 07747

Sponsors and Collaborators

  • Jena University Hospital

Investigators

  • Principal Investigator: Sven Möbius-Winkler, MD, Universityhospital Jena

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Jena University Hospital
ClinicalTrials.gov Identifier:
NCT04450459
Other Study ID Numbers:
  • SMW 08
First Posted:
Jun 29, 2020
Last Update Posted:
Aug 11, 2022
Last Verified:
Aug 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Keywords provided by Jena University Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 11, 2022